CLINICAL_TRIALS
trial_result
· 2014-07-24
Clinical Trial Update: STRIDE - STimulating Immune Response In aDvanced brEast Cancer [Phase 3]
Summary
A Phase 3 trial called STRIDE evaluating an immunotherapy approach for advanced breast cancer was terminated, with results posted in July 2014.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: EMD Serono | Conditions: Breast Cancer | Phase 3 | Status: TERMINATED | Results posted: 2014-07-24